Perkins Coie Trust Company’s Boston Scientific BSX Stock Holding History

Perkins Coie Trust Company’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-28	Closed	-$2.82K	–	307
2025 Q1	$2.82K	Buy	28 +6	+27%	+$604	﹤0.01%	274
2024 Q4	$1.96K	Hold	22	–	–	﹤0.01%	261
2024 Q3	$1.84K	Hold	22	–	–	﹤0.01%	269
2024 Q2	$1.69K	Hold	22	–	–	﹤0.01%	259
2024 Q1	$1.51K	Hold	22	–	–	﹤0.01%	233
2023 Q4	$1.27K	Sell	22 -96	-81%	-$5.12K	﹤0.01%	252
2023 Q3	$6.23K	Buy	+118	New	+$6.19K	﹤0.01%	266
2020 Q3	–	Sell	-17	Closed	-$1K	–	258
2020 Q2	$1K	Hold	17	–	–	﹤0.01%	257
2020 Q1	$1K	Buy	+17	New	+$664	﹤0.01%	282

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Perkins Coie Trust Company's BSX Position: Q2 2025 in Review

Perkins Coie Trust Company sold out of Boston Scientific (BSX) in Q2 2025, closing a stake of 28 shares — an estimated $2.82K sold.

Perkins Coie Trust Company first reported a position in BSX in Q1 2020 and held it in 9 quarters. The position peaked at $6.23K in Q3 2023. 1,687 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

Perkins Coie Trust Company reported no remaining Boston Scientific position as of Q2 2025 after selling out during the quarter.
Perkins Coie Trust Company sold 28 Boston Scientific shares in Q2 2025, an estimated $2.82K.
Perkins Coie Trust Company first reported a position in Boston Scientific in Q1 2020 and held it in 9 quarters.
Perkins Coie Trust Company's Boston Scientific position peaked at $6.23K in Q3 2023.
1,687 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Perkins Coie Trust Company's 13F filing for Q2 2025, filed 10 Jul 2025.